Related Experiment Video

Updated: Oct 5, 2026

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

[Chemotherapy for gliomas based on the expression levels of drug resistant genes]

Y Matsumoto1, K Morisaki, K Miyake

  • 1Department of Neurological Surgery, Kagawa Medical University, 1750-1 Iketo, Miki-cho, Kita-gun, Kagawa 761-0793, Japan.

No Shinkei Geka. Neurological Surgery
|August 24, 2001
PubMed

Insights

Detecting drug-resistant genes aids chemotherapy for malignant glioma. This approach showed 78% of patients free from tumor progression, highlighting the necessity of gene expression assays for personalized cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • Drug resistance is a major challenge in treating human malignancies with chemotherapy.
  • Multidrug resistance (MDR) mechanisms, both typical and atypical, are extensively studied.
  • Identifying specific drug-resistant genes is crucial for effective cancer therapy.

Purpose:

  • To measure the expression of key drug-resistant genes (MDR-1, MXR, MRP1, MRP2, TopoII alpha, MGMT, GST-pi) in malignant glioma specimens.
  • To correlate gene expression profiles with patient response to chemotherapy.
  • To establish the utility of gene expression assays for guiding personalized chemotherapy selection.

Summary:

  • Expression of MDR-1, MXR, MRP1, MRP2, TopoII alpha, MGMT, and GST-pi genes was analyzed in 14 malignant glioma samples using reverse transcription polymerase chain reaction.
  • Anticancer drugs were selected for each patient based on their specific drug-resistant gene expression profiles.
  • Preliminary results show 78% (7/9) of treated glioma patients experienced no tumor progression, suggesting treatment efficacy.

Impact:

  • Gene expression assays for drug resistance can enable rapid detection of chemotherapy sensitivity in malignant glioma patients.
  • This personalized approach has the potential to improve treatment outcomes and overcome drug resistance.
  • The findings underscore the importance of molecular profiling for optimizing cancer chemotherapy.

More Related Videos

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...